Spondyloarthritis [EULAR HL 2023] Spondyloarthritis I – Clinical (Non-therapeutic) 20 Jun 2023 Author: Gizem Ayan Marques et al. (OP005) searched the sustainability of a baseline diagnosis of axSpA when reviewed after 2 years and showed that most of the patients can be…
Spondyloarthritis II - therapeutic [EULAR HL 2023] Spondyloarthritis II – therapeutic 20 Jun 2023 Author: Stefan Dinescu Baraliakos et al. (POS1106) studied the achievement of low disease activity in patients with axSpA treated with bimekizumab over 52 weeks. A greater proportion of patients with both nr-axSpA and r-axSpA obtained LDA at…
Imaging [EULAR HL 2023] Imaging 20 Jun 202323 Jun 2023 Author: Diego Benavent Molina Collada et al (OP0171) examined the added value of FDG-PET/CT for detecting aortitis in patients with giant cell arteritis (GCA). They found that FDG-PET/CT can detect…
Osteoarthritis and Osteoporosis [EULAR HL 2023] Osteoarthritis & Osteoporosis 20 Jun 2023 Author: Anastasia Madenidou Wittoek et al. (OP0071) explored the benefits of denosumab in patients with erosive hand OA. One hundred patients with erosive hand OA were randomly allocated to placebo…
Metabolic & crystal arthropathies [EULAR HL 2023] Metabolic & crystal arthropathies 20 Jun 2023 Author: Juan C Sarmiento-Monroy Mccormick et al. (OP0258) evaluated the incident gout risk among metformin-treated patients with type 2 diabetes initiating SGLT2i vs. other second-line treatments in a population-based cohort study…
Connective Tissue Diseases and Vasculitis [EULAR HL 2023] Other connective tissue diseases and vasculitis 20 Jun 202323 Jun 2023 Author: Cristiana Sieiro Santos Izuka et al. (OP0096) identified the significant immune cells forming systemic immune-mediated diseases and stratified all patientsaccordingly, using immunophenotyping and transcriptomic data. Genes associated with adaptive immune response in naïve CD8+ T cells were found in cluster…
HPR [EULAR HL 2023] Health Professionals in Rheumatology 20 Jun 202323 Jun 2023 Author: Anne-Kathrin Rausch Farisogullari et al. (OPI176-HPR) presented the evidence supporting the 2023 EULAR recommendations for the non-pharmacological management of fatigue, which is efficacious and safe, in people with inflammatory rheumatic…
Paediatrics [EULAR HL 2023] Paediatrics 20 Jun 2023 Author: Erdal Sag There were two major topics for paediatric RMD at EULAR 2023 congress. The first one is new treatment options and the other one is the new biomarkers…
Rare & Autoinflammatory diseases [EULAR HL 2023] Rare and autoinflammatory diseases 20 Jun 2023 M. Lanzillotta et al. (OP0251) characterized the epidemiology, clinical manifestations, and response to treatment of IgG4-RD patients in Europe. 1079 individuals with were screened but only 735 were diagnosed with IgG4-RD. 45% had multiorgan involvement.…
People with Arthritis/Rheumatism across Europe (PARE) [EULAR HL 2023] PARE 20 Jun 2023 Author: Sladjana Rumpl Tunjic Laura Campbell et al. (OP0009) explored if living with a long-term health condition can increase the likelihood of experiencing poor mental health. Having access to high-quality resources to…